Not logged in Share Save
Share Save
Share Save
Share Save
Share Save
Share Save
XIAP overexpressing Inflammatory Breast Cancer Patients have high Infiltration of immunosuppressive subsets and increased TNFR1 signaling targetable with Birinapant, a pan- IAP antagonist Devi, G.; Van Berckelaer, C.; Van Laere, S.; Geradts, J.; Lee, S.; Morse, M.; Dirix, L.; Kockx, M.; Bertucci, F.; Van Dam, P. Share Save
Androgen deprivation induces double-null prostate cancer via aberrant nuclear export and ribosomal biogenesis through HGF and Wnt activation Kim, Won Kyung; Buckley, Alyssa J.; Lee, Dong-Hoon; Hiroto, Alex; Nenninger, Christian H.; Olson, Adam W.; Wang, Jinhui; Li, Zhuo; Vikram, Rajeev; Adzavon, Yao Mawulikplimi; Yau, Tak-yu; Bao, Yigang; Kahn, Michael; Geradts, Joseph; Xiao, Guang-Qian; Sun, Zijie Share Save
Share Save
Share Save
Share Save
Stromal androgen signaling acts as tumor niches to drive prostatic basal epithelial progenitor-initiated oncogenesis Hiroto, Alex; Kim, Won Kyung; Pineda, Ariana; He, Yongfeng; Lee, Dong-Hoon; Le, Vien; Olson, Adam W.; Aldahl, Joseph; Nenninger, Christian H.; Buckley, Alyssa J.; Xiao, Guang-Qian; Geradts, Joseph; Sun, Zijie Share Save
Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinoma Rebbeck, Clare A.; Xian, Jian; Bornelov, Susanne; Geradts, Joseph; Hobeika, Amy; Geiger, Heather; Alvarez, Jose Franco; Rozhkova, Elena; Nicholls, Ashley; Robine, Nicolas; Lyerly, Herbert K.; Hannon, Gregory J. Share Save
Share Save
Share Save
Outcomes of Hormone-Receptor Positive, HER2-Negative Breast Cancers by Race and Tumor Biological Features Benefield, Halei C.; Reeder-Hayes, Katherine E.; Nichols, Hazel B.; Calhoun, Benjamin C.; Love, Michael, I; Kirk, Erin L.; Geradts, Joseph; Hoadley, Katherine A.; Cole, Stephen R.; Earp, H. Shelton; Olshan, Andrew F.; Carey, Lisa A.; Perou, Charles M.; Troester, Melissa A. Share Save
Outcomes of hormone-receptor positive, HER2-negative breast cancers by race and tumor biologic features Earp, H. Shelton; Olshan, Andrew F.; Carey, Lisa A.; Perou, Charles M.; Troester, Melissa A.; Benefield, Halei C.; Reeder-Hayes, Katherine E.; Nichols, Hazel B.; Calhoun, Benjamin C.; Love, Michael, I; Sun, Xuezheng; Kirk, Erin L.; Geradts, Joseph; Hoadley, Katherine A.; Cole, Stephen R. Share Save
Share Save
Reversion and non-reversion mechanisms of resistance to PARP inhibitor or platinum chemotherapy in BRCA1/2-mutant metastatic breast cancer Waks, A. G.; Coheny, O.; Kochupurakkal, B.; Kim, D.; Dunn, C. E.; Buendia, J. Buendia; Wander, S.; Helvie, K.; Lloyd, M. R.; Marini, L.; Hughes, M. E.; Freeman, S. S.; Ivy, S. P.; Geradts, J.; Isakoff, S.; LoRusso, P.; Adalsteinsson, V. A.; Tolaney, S. M.; Matulonis, U.; Krop, I. E.; D'Andrea, A. D.; Winer, E. P.; Lin, N. U.; Shapiro, G. I.; Wagle, N. Share Save
Androgen receptor with short polyglutamine tract preferably enhances Wnt/β-catenin-mediated prostatic tumorigenesis He, Yongfeng; Mi, Jiaqi; Olson, Adam; Aldahl, Joseph; Hooker, Erika; Yu, Eun-Jeong; Le, Vien; Lee, Dong-Hoon; Kim, Won Kyung; Robins, Diane M.; Geradts, Joseph; Sun, Zijie Share Save
.png){kind=icon}
.png){kind=icon}
Not logged in.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
